{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:11:27Z","timestamp":1786119087710,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Thrombotic and thromboembolic events are a common and potentially preventable complication in multitrauma patients, and substantial quality improvement efforts are directed at prevention. The results of several randomized controlled trials (RCTs) related to the association between tranexamic acid (TXA) and thrombotic\/thromboembolic events have demonstrated conflicting results. We aimed to address this by examining whether prehospital TXA was associated with higher rates of thrombotic\/thromboembolic events in a harmonized data set from three large multicenter RCTs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>We analyzed data using a harmonized data set from three RCTs examining the effects of prehospital TXA: The Pre-Hospital Anti-fibrinolytics for Traumatic Coagulopathy and Hemorrhage Study (PATCH trial), Study of Tranexamic Acid During Air and Ground Medical Prehospital Transport Trial (STAAMP trial) and the Prehospital TXA for TBI trial, part of the Resuscitation Outcomes Consortium (ROC trial). Outcomes included deep venous thrombosis (DVT), pulmonary embolism (PE), myocardial infarction, stroke, combined venous thrombotic\/thromboembolic events (VTE), and combined arterial thrombotic\/thromboembolic events. Multivariable regression was used to adjust for TXA administration, sex, age, injury severity score, Glasgow Coma Scale, shock index, and 24-hour red cell transfusion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>There were no differences in myocardial infarction, stroke, arterial thrombotic\/thromboembolic events, DVT, PE, or VTE in patients who were randomized to TXA compared with those who were not. On univariate analysis, rates of PE, DVT and VTE were significantly higher in the PATCH cohort compared with STAAMP and ROC cohorts, but patients in PATCH had significantly higher injury severity scores and chest trauma when compared with those in ROC and STAAMP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>\n                      This multicenter database combining three large RCTs showed that randomization to TXA was not associated with higher rates of arterial and VTE. The higher rates of thrombotic\/thromboembolic events observed in the PATCH trial may be explained by higher injury severity as well as protocolized screening. (\n                      <jats:italic toggle=\"yes\">J Trauma Acute Care Surg.<\/jats:italic>\n                      2026;101: 48\u201356. Copyright \u00a9 2026 Wolters Kluwer Health, Inc. All rights reserved.)\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LEVEL OF EVIDENCE:<\/jats:title>\n                    <jats:p>Sub-analysis of randomized controlled trials; Level II.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ta.0000000000005010","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T14:00:14Z","timestamp":1776952814000},"page":"48-56","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Thrombotic and thromboembolic events were not associated with tranexamic acid in three large randomized controlled trials"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2137-1834","authenticated-orcid":false,"given":"Alexandra M.P.","family":"Brito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Kenny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswadev","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Neal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Gruen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Medcalf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Rowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason L.","family":"Sperry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin A.","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"issue":"5","key":"R1-20260623","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.3390\/jcm10051030","article-title":"Efficacy and safety of tranexamic acid in emergency trauma: a systematic review and meta-analysis","volume":"10","author":"Al-Jeabory","year":"2021","journal-title":"J Clin Med"},{"issue":"10","key":"R2-20260623","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jama.2020.8958","article-title":"Effect of out-of-hospital tranexamic acid vs placebo on 6-month functional neurologic outcomes in patients with moderate or severe traumatic brain injury","volume":"324","author":"Rowell","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"R3-20260623","first-page":"11","article-title":"Tranexamic","volume":"156","author":"Guyette","year":"2020","journal-title":"JAMA Surg"},{"issue":"5","key":"R4-20260623","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/TA.0000000000004315","article-title":"Prehospital tranexamic acid is associated with a survival benefit without an increase in complications: results of two harmonized randomized clinical trials","volume":"97","author":"Mazzei","year":"2024","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"R5-20260623","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa2215457","article-title":"Prehospital tranexamic acid for severe trauma","volume":"389","author":"Gruen","year":"2023","journal-title":"N Engl J Med"},{"issue":"2","key":"R6-20260623","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archsurg.2011.287","article-title":"Military application of tranexamic acid in trauma emergency resuscitation (MATTERs) study","volume":"147","author":"Morrison","year":"2012","journal-title":"Arch Surg"},{"issue":"Suppl 1","key":"R7-20260623","first-page":"S139","article-title":"The risk of thromboembolic events with early intravenous 2- and 4-g bolus dosing of tranexamic acid compared to placebo in patients with severe traumatic bleeding: a secondary analysis of a randomized, double-blind, placebo-controlled, single-center trial","volume":"62","author":"Spinella","year":"2022","journal-title":"Transfusion"},{"issue":"1","key":"R8-20260623","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/MBC.0000000000000983","article-title":"The incidence of venous thromboembolic events in trauma patients after tranexamic acid administration: an EAST multicenter study","volume":"32","author":"Rivas","year":"2021","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"3","key":"R9-20260623","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s00068-021-01827-5","article-title":"The effect of prehospital tranexamic acid on outcome in polytrauma patients with associated severe brain injury","volume":"48","author":"van Wessem","year":"2022","journal-title":"Eur J Trauma Emerg Surg"},{"issue":"11","key":"R10-20260623","doi-asserted-by":"crossref","first-page":"111008","DOI":"10.1016\/j.injury.2023.111008","article-title":"Does tranexamic acid increase venous thromboembolism risk among trauma patients? A prospective multicenter analysis across 17 level I trauma centers","volume":"54","author":"Knowlton","year":"2023","journal-title":"Injury"},{"issue":"1","key":"R11-20260623","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/TA.0000000000002061","article-title":"Tranexamic acid administration is associated with an increased risk of posttraumatic venous thromboembolism","volume":"86","author":"Myers","year":"2019","journal-title":"J Trauma Acute Care Surg"},{"key":"R12-20260623","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/ALN.0000000000004036","article-title":"Temporal transitions in fibrinolysis after trauma: adverse outcome is principally related to late hypofibrinolysis","volume":"136","author":"Rossetto","year":"2021","journal-title":"Anesthesiology"},{"issue":"1","key":"R13-20260623","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13054-021-03701-7","article-title":"The impact of prehospital tranexamic acid on mortality and transfusion requirements: match-pair analysis from the nationwide German TraumaRegister DGU","volume":"25","author":"Imach","year":"2021","journal-title":"Crit Care"},{"key":"R14-20260623","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.thromres.2019.05.003","article-title":"Risk of venous and arterial thrombosis in non-surgical patients receiving systemic tranexamic acid: a systematic review and meta-analysis","volume":"179","author":"Chornenki","year":"2019","journal-title":"Thromb Res"},{"issue":"10241","key":"R16-20260623","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(20)30848-5","article-title":"Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial","volume":"395","author":"Roberts","year":"2020","journal-title":"The Lancet"},{"key":"R17-20260623","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.3389\/fimmu.2020.02085","article-title":"The immunologic effect of early intravenous two and four gram bolus dosing of tranexamic acid compared to placebo in patients with severe traumatic bleeding (TAMPITI): a randomized, double-blind, placebo-controlled, single-center trial","volume":"11","author":"Spinella","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"R18-20260623","first-page":"27","article-title":"Duplex ultrasound screening for deep vein thrombosis in asymptomatic trauma patients: a survey of individual trauma surgeon opinions and current trauma center practices","volume":"70","author":"Haut","year":"2011","journal-title":"J Trauma"},{"issue":"5","key":"R19-20260623","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/TA.0000000000003104","article-title":"Trauma patients at risk for venous thromboembolism who undergo routine duplex ultrasound screening experience fewer pulmonary emboli: a prospective randomized trial","volume":"90","author":"Kay","year":"2021","journal-title":"J Trauma Acute Care Surg"},{"issue":"Suppl 2","key":"R21-20260623","doi-asserted-by":"crossref","first-page":"e227S","DOI":"10.1378\/chest.11-2297","article-title":"Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Gould","year":"2012","journal-title":"Chest"},{"issue":"3","key":"R22-20260623","first-page":"CD008303","article-title":"Thromboprophylaxis for trauma patients","volume":"2013","author":"Barrera","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"24","key":"R23-20260623","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1056\/NEJM199412153312401","article-title":"A prospective study of venous thromboembolism after major trauma","volume":"331","author":"Geerts","year":"1994","journal-title":"N Engl J Med"},{"issue":"1","key":"R24-20260623","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/TA.0000000000001308","article-title":"Abnormalities in fibrinolysis at the time of admission are associated with deep vein thrombosis, mortality, and disability in a pediatric trauma population","volume":"82","author":"Leeper","year":"2017","journal-title":"J Trauma Acute Care Surg"},{"issue":"4","key":"R25-20260623","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jamcollsurg.2016.01.006","article-title":"Acute fibrinolysis shutdown after injury occurs frequently and increases mortality: a multicenter evaluation of 2,540 severely injured patients","volume":"222","author":"Moore","year":"2016","journal-title":"J Am Coll Surg"},{"key":"R26-20260623","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jss.2017.04.028","article-title":"Tranexamic acid is associated with increased mortality in patients with physiological fibrinolysis","volume":"220","author":"Moore","year":"2017","journal-title":"J Surg Res"},{"key":"R27-20260623","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.amjsurg.2023.09.034","article-title":"Analysis of fibrinolytic shutdown in trauma patients with traumatic brain injury","volume":"227","author":"Favors","year":"2024","journal-title":"Am J Surg"},{"issue":"3","key":"R28-20260623","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/TA.0000000000004122","article-title":"Association of fibrinolysis phenotype with patient outcomes following traumatic brain injury","volume":"96","author":"Durbin","year":"2024","journal-title":"J Trauma Acute Care Surg"},{"issue":"1","key":"R29-20260623","doi-asserted-by":"crossref","first-page":"19107","DOI":"10.1038\/s41598-022-23912-4","article-title":"Hyperfibrinolysis and fibrinolysis shutdown in patients with traumatic brain injury","volume":"12","author":"Nakae","year":"2022","journal-title":"Sci Rep"},{"issue":"5","key":"R30-20260623","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.injury.2023.02.013","article-title":"Persistent fibrinolysis shutdown is associated with increased mortality in traumatic pancreatic injury","volume":"54","author":"Liu","year":"2023","journal-title":"Injury"},{"issue":"10","key":"R31-20260623","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17100","article-title":"The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients","volume":"17","author":"Roberts","year":"2013","journal-title":"Health Technol Assess"},{"issue":"2","key":"R32-20260623","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.amj.2021.11.009","article-title":"To tranexamic acid or not to tranexamic acid? Accuracy of antifibrinolytic administration at altitude","volume":"41","author":"DeVitis","year":"2022","journal-title":"Air Med J"},{"issue":"4","key":"R33-20260623","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1177\/00031348231209525","article-title":"Are data driving our ambulances? Liberal use of tranexamic acid in the prehospital setting","volume":"90","author":"Brito","year":"2024","journal-title":"Am Surg"},{"issue":"1","key":"R34-20260623","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12959-023-00540-0","article-title":"Tranexamic acid for haemostasis and beyond: does dose matter?","volume":"21","author":"Lam","year":"2023","journal-title":"Thromb J"},{"issue":"10","key":"R35-20260623","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1111\/jth.15015","article-title":"Sex-dependent effects of tranexamic acid on blood-brain barrier permeability and the immune response following traumatic brain injury in mice","volume":"18","author":"Daglas","year":"2020","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Trauma and Acute Care Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TA.0000000000005010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:33:14Z","timestamp":1786037594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/TA.0000000000005010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ta.0000000000005010","relation":{},"ISSN":["2163-0755","2163-0763"],"issn-type":[{"value":"2163-0755","type":"print"},{"value":"2163-0763","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]},"assertion":[{"value":"2025-11-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}